PRO MEDICUS LIMITED — Director's Dealing 2012

Mar 7, 2012

Appendix 3Y Change of Director’s Interest Notice

Listing Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Pro Medicus Limited ABN 25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Peter Terence KEMPEN
Date of last notice	30 November 2011

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Ordinary fully paid shares in Pro Medicus Limited held by the Elaine Kempen Superannuation Fund of which the Director is a Trustee and Member
Date of change	5 March 2012 7 March 2012 8 March 2012
No. of securities held prior to change	278,082 ordinary shares 200,000 ordinary share options
Class	Ordinary shares
Number acquired	26,136 – 5 March 2012 10,000 – 7 March 2012 13,864 – 8 March 2012
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.25 cents per share for 6,136 shares $0.26 cents per share for 43,864 shares
No. of securities held after change	328,082 ordinary shares 200,000 ordinary share options

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Nature of change On market purchase Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to	N/A
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details and
an estimated valuation
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed	No
above traded during a+closed period where prior
written clearance was required?
If so, was prior written clearance provided to allow the	N/A
trade to proceed during this period?
If prior written clearance was provided, on what date	N/A
was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

For and on behalf of Pro Medicus Limited

==> picture [125 x 59] intentionally omitted <==

Clayton Hatch Company Secretary 8 March 2012

• See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002